From: Self-medication practice and associated factors among pregnant women in Addis Ababa, Ethiopia
Medicines used | n (%)* | Trimester, n | US FDA risk category | ||
---|---|---|---|---|---|
1st | 2nd | 3rd | |||
Paracetamol | 55 (49.1) | 27 | 22 | 6 | B |
Amoxicillin | 26 (23.2) | 12 | 14 | Â | B |
Tinidazole | 5 (4.5) | 2 | 2 | 1 | C |
Metronidazole | 4 (3.6) | 1 | 2 | 1 | B |
Ibuprofen | 6 (5.4) | 2 | 4 | Â | C |
Albendazole | 6 (5.4) | 4 | 2 | Â | C |
Panadol | 7 (6.3) | 3 | 4 | Â | D |
Diclofenac | 5 (4.5) | 1 | 3 | 1 | C |
Mebendazole | 2 (1.8) | 1 | 1 | Â | C |
Augmentin (amoxicillin + clavulanate) | 1(0.9) | Â | Â | 1 | B |
Azithromycin | 1 (0.9) | Â | 1 | Â | B |
Tetracycline | 3 (2.7) | Â | 3 | Â | D |
Magnesium trisilicate | 2 (1.8) | 1 | 1 | Â | B |
Ciprofloxacin | 4 (3.6) | 1 | 3 | Â | D |
Aspirin | 3 (2.7) | 1 | 1 | 1 | D |
Bactrim (sulfamethoxazole + trimethoprim) | 2 (1.8) | 2 | Â | Â | D |
Ampicillin | 2 (1.8) | Â | 2 | Â | B |
Depo-provera (medroxyprogesterone) | 1 (0.9) | 1 | Â | Â | X |
Unknown medicines | 3 (2.7) | 2 | 1 | Â | Â |